TANGO THERAPEUTICS, INC. (TNGX) FY2026 YTD Q2 P&L / Income Statement

P&L / Income Statement

2026-01-01 to 2026-06-30

Swipe to see the full flow
TANGO THERAPEUTICS, INC. (TNGX) FY2026 YTD Q2 P&L / Income StatementIncome statement for 2026-01-01 through 2026-06-30. Consolidated revenue, costs and expenses.REVENUEOPERATINGPRE-TAXNETLoss from operationsTotal operating expensesTotal operating expensesTotal other income, netLoss before income taxesNet lossProvision for income taxesTotal other income, netTotal other income, net$7.70 MLoss before income taxesLoss beforeincome taxes−$100.85 MCollaboration revenueCollaboration revenue$0.00Loss from operationsLoss from operations−$108.56 MNet lossNet loss−$100.86 MTotal operating expensesTotal operatingexpenses$108.56 MProvision for income taxesProvision forincome taxes$2.00 KTotal operating expensesTotal operating expenses$108.56 M
Chart details

TANGO THERAPEUTICS, INC. (TNGX) FY2026 YTD Q2 P&L / Income Statement

Income statement for 2026-01-01 through 2026-06-30. Consolidated revenue, costs and expenses.

Collaboration revenue
0 US dollars
Total operating expenses
108,555,000 US dollars
Loss from operations
negative 108,555,000 US dollars
Total other income, net
7,701,000 US dollars
Loss before income taxes
negative 100,854,000 US dollars
Provision for income taxes
2,000 US dollars
Net loss
negative 100,856,000 US dollars
Total operating expenses
108,555,000 US dollars

Chart connections

  • Revenue minus operating expenses equals operating income.
  • Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.
TANGO THERAPEUTICS, INC. (TNGX) FY2026 YTD Q2 P&L / Income Statement Sankey chart
Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG

Newsletter

Get the teardowns by email

Subscribe if you want the public-company teardowns in your inbox when they're released.

Product waitlist

Health Check and Teardown for your own company

A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!